X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,708 | 126,184 | 8,134 | 76,793 | 3,035 |
| Receivables | 917 | 1,998 | N/A | 1,608 | 1,345 |
| TOTAL | $83,307 | $129,278 | $9,339 | $79,530 | $5,716 |
| Non-Current Assets | |||||
| PPE Net | 1,237 | 403 | 241 | 421 | 519 |
| Intangibles | 27,109 | 27,109 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,218 | 3,908 | 364 | 1,303 | 1,369 |
| TOTAL | $39,564 | $31,420 | $605 | $1,724 | $1,888 |
| Total Assets | $122,871 | $160,698 | $9,944 | $81,254 | $7,604 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,687 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,144 | 2,088 | 2,969 | 4,207 | 3,944 |
| Accrued Expenses | 8,018 | 6,461 | 3,251 | 5,779 | 2,156 |
| Other current liabilities | N/A | N/A | N/A | N/A | 2,593 |
| TOTAL | $11,948 | $9,447 | $7,907 | $10,680 | $12,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,178 | 20,097 | 8,145 | 9,922 | 10,127 |
| Deferred Revenues | N/A | N/A | N/A | 694 | 504 |
| Other Non-Current Liabilities | 4,946 | 1,934 | 6,303 | 9 | 87 |
| TOTAL | $38,124 | $22,031 | $14,448 | $11,867 | $12,268 |
| Total Liabilities | $50,072 | $31,478 | $22,355 | $22,547 | $24,328 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 579 | 537 | 81 | N/A | N/A |
| Common Shares | 16 | 16 | N/A | 15 | 1 |
| Retained earnings | -194,175 | -132,044 | -79,237 | -92,265 | -58,388 |
| Other shareholders' equity | -119 | -119 | 64,675 | 127 | 40,672 |
| TOTAL | $72,799 | $129,220 | $-12,411 | $58,707 | $-16,724 |
| Total Liabilities And Equity | $122,871 | $160,698 | $9,944 | $81,254 | $7,604 |